G’morning to ya! Nicholas St. Fleur here to fill in for Ed following this Labor Day weekend. I must admit, I don’t have any flamboyant coffee flavors to share this morning. My cup of joe of choice is always a medium roast straight from my mom’s Keurig. I take it black and top it off with room-temperature water because I like to drink my coffee fast and I can’t do that if it’s scorching hot. Sorry it’s not more exciting. But what is exciting is the lineup of pharma news we’ve got to share with you to give your morning a boost. …
A major hurdle stands in the way of the development of new vaccines, as well as the critical studies needed to determine the best way to use these important tools, the Coalition for Epidemic Preparedness Innovations (CEPI) warned in a letter published Tuesday in the journal Nature, STAT writes. Part of the problem is that testing new vaccines against placebos is unethical at this point, and testing them against the vaccines that are already widely used is tough because they are in such high demand globally.
What will the side effects from a booster shot look like? STAT asked experts for their answers. They cautioned, their responses were like “reading tea leaves,” as one expert put it. The data on adverse effects from a third vaccine dose are lacking, but one study of Pfizer (PFE) -BioNTech (BNTX) booster shots given to older adults in Israel suggests there aren’t any new concerns.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect